Logo-jcvtr

Read This Article

Article History

Submitted: 20 Nov 2020
Accepted: 24 Jan 2021
ePublished: 16 Feb 2021

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

J Cardiovasc Thorac Res. 2021;13(1): 90-91.
doi: 10.34172/jcvtr.2021.19
PMID: 33815709
PMCID: PMC8007892
Scopus ID: 85106479547
  Abstract View: 795
  PDF Download: 698
  Full Text View: 453

Commentary

Upgrading treatment strategies of cardiovascular diseases using biotechnology: Are we still there?

Sara Pahlavan 1* ORCID logo, Sahand Abrishami 2

1 Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran
2 Department of Cardiovascular Surgery, Imam Khomeini Hospital Complex, Tehran University Medical Center, Tehran, Iran
*Corresponding Author: *Corresponding Author: Sara Pahlavan, Email: , Email: sarapahlavan@royaninstitute.org
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 796

Your browser does not support the canvas element.

PDF Download: 698

Your browser does not support the canvas element.

Full Text View: 453

Your browser does not support the canvas element.